Varian Medical Systems, Inc. (VAR) Stake Increased by Hardman Johnston Global Advisors LLC

Hardman Johnston Global Advisors LLC grew its stake in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 0.5% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 229,872 shares of the medical equipment provider’s stock after acquiring an additional 1,235 shares during the quarter. Hardman Johnston Global Advisors LLC owned about 0.25% of Varian Medical Systems worth $23,001,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the company. BP PLC bought a new stake in shares of Varian Medical Systems during the 3rd quarter valued at $1,100,000. Baillie Gifford & Co. lifted its position in shares of Varian Medical Systems by 16.6% during the 3rd quarter. Baillie Gifford & Co. now owns 117,375 shares of the medical equipment provider’s stock valued at $11,745,000 after acquiring an additional 16,708 shares during the period. Parametrica Management Ltd bought a new stake in shares of Varian Medical Systems during the 3rd quarter worth $229,000. Victory Capital Management Inc. lifted its position in shares of Varian Medical Systems by 3.2% during the 3rd quarter. Victory Capital Management Inc. now owns 21,593 shares of the medical equipment provider’s stock worth $2,161,000 after buying an additional 673 shares during the last quarter. Finally, Crossmark Global Holdings Inc. bought a new stake in shares of Varian Medical Systems during the 3rd quarter worth $1,458,000. Hedge funds and other institutional investors own 99.15% of the company’s stock.

Several analysts recently weighed in on the company. Robert W. Baird restated a “neutral” rating and set a $99.00 price objective (up from $89.00) on shares of Varian Medical Systems in a research report on Friday, July 14th. Zacks Investment Research downgraded Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. BidaskClub downgraded Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Thursday, August 3rd. BTIG Research downgraded Varian Medical Systems from a “buy” rating to a “neutral” rating in a research report on Thursday, September 7th. They noted that the move was a valuation call. Finally, Royal Bank Of Canada restated a “hold” rating and set a $100.00 price objective on shares of Varian Medical Systems in a research report on Friday, September 1st. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company’s stock. Varian Medical Systems presently has a consensus rating of “Hold” and an average target price of $97.83.

Varian Medical Systems (NYSE:VAR) last posted its earnings results on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. The firm had revenue of $739.00 million for the quarter, compared to analysts’ expectations of $741.69 million. During the same quarter last year, the company posted $1.03 EPS. The firm’s revenue was down 1.1% on a year-over-year basis.

In other Varian Medical Systems news, EVP Kolleen T. Kennedy sold 1,088 shares of the company’s stock in a transaction that occurred on Tuesday, September 12th. The stock was sold at an average price of $107.33, for a total transaction of $116,775.04. Following the transaction, the executive vice president now owns 27,688 shares in the company, valued at approximately $2,971,753.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Dow R. Wilson sold 15,059 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $96.48, for a total value of $1,452,892.32. Following the transaction, the insider now owns 81,835 shares in the company, valued at approximately $7,895,440.80. The disclosure for this sale can be found here. Insiders have sold a total of 56,887 shares of company stock worth $5,790,308 in the last quarter. Company insiders own 0.91% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.com-unik.info/2017/11/02/varian-medical-systems-inc-var-stake-increased-by-hardman-johnston-global-advisors-llc.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

What are top analysts saying about Varian Medical Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Varian Medical Systems Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit